Authors:
SCHWARTSMANN G
HOROWITZ M
DILEONE L
SANDER E
CAMPOS O
FERREIRA AF
SCHUNEMANN H
VIEGAS MAV
CANCELA AI
MANS DRA
Citation: G. Schwartsmann et al., PHASE-I TRIAL OF THE BOMBESIN RECEPTOR ANTAGONIST RC-3095 IN PATIENTSWITH REFRACTORY SOLID TUMORS, Annals of oncology, 9, 1998, pp. 651-651
Authors:
SCHWARTSMANN G
DILEONE L
CALDAS APF
CAMPOS O
CANCELA AI
VIEGAS MAV
MANS DRA
Citation: G. Schwartsmann et al., PHASE-I AND PHARMACOKINETIC STUDY OF LOW-DOSE, 3-TIMES DAILY ORAL ETOPOSIDE IN PATIENTS WITH REFRACTORY SOLID TUMORS, Annals of oncology, 9, 1998, pp. 660-660
Authors:
MONDIN C
VONPOSER G
MANS DRA
FERRAZ A
DIEL CL
DELIMA C
LOPES RM
BARROS M
DAROCHA AB
VARELLA D
CRAGG G
SCHWARTSMANN G
Citation: C. Mondin et al., TARGETED PLANT COLLECTION AS A RATIONAL MEANS TO ACQUIRE CANDIDATE ANTICANCER COMPOUNDS FOR SCREENING, Annals of oncology, 9, 1998, pp. 134-134
Authors:
SCHWARTSMANN G
MANS DRA
DILEONE L
CALDAS APF
CAMPOS O
SANDER E
BORTOLINI M
VIEGAS MAV
CANCELA AI
Citation: G. Schwartsmann et al., PHASE-I AND PHARMACOKINETIC STUDY OF ORAL ETOPOSIDE GIVEN 3-TIMES DAILY ORALLY TO PATIENTS WITH REFRACTORY SOLID TUMORS, Annals of oncology, 9, 1998, pp. 252-252
Authors:
DAROCHA AB
MANS DRA
FONESCA VM
RUSCHEL C
SCHWARTSMANN G
Citation: Ab. Darocha et al., EFFECTS OF ORNITHINE DECARBOXYLASE (ODC) INHIBITION USING D,I-ALPHA-DIFLUOROMETHYLORNITHINE (DFMO), ON THE IN-VITRO INVASIVENESS OF CULTURED HUMAN GLIOBLASTOMA CELLS, Annals of oncology, 9, 1998, pp. 274-274
Authors:
SCHWARTSMANN G
HOROWITZ M
DILEONE L
SANDER E
CAMPOS O
FERREIRA AF
SCHUNEMANN H
VIEGAS MAV
CANCELA AI
MANS DRA
Citation: G. Schwartsmann et al., PHASE-I TRIAL OF THE BOMBESIN RECEPTOR ANTAGONIST RC-3095 IN PATIENTSWITH REFRACTORY SOLID TUMORS, Annals of oncology, 9, 1998, pp. 420-420
Authors:
MANS DRA
DAROCHA AB
RUSCHEL C
FONSECA VM
BRAGA A
SCHWARTSMANN G
Citation: Dra. Mans et al., RADIOSENSITIZATION OF CULTURED HUMAN GLIOBLASTOMA CELLS THROUGH INHIBITION OF PROTEIN-KINASE-C ACTIVITY, Annals of oncology, 9, 1998, pp. 521-521
Authors:
SCHWARTSMANN G
SPRINZ E
KROMFIELD M
KALAKUN L
SANDER E
PROLLA G
DILEONE L
GERHARDT L
MANS DRA
Citation: G. Schwartsmann et al., CLINICAL AND PHARMACOKINETIC STUDY OF ORAL ETOPOSIDE IN PATIENTS WITHAIDS-RELATED KAPOSIS-SARCOMA WITH NO PRIOR EXPOSURE TO CYTOTOXIC THERAPY, Journal of clinical oncology, 15(5), 1997, pp. 2118-2124
Authors:
SCHWARTSMANN G
SPRINZ E
KALAKUN L
YAMAGUSHI N
SANDER E
GRIVICICH I
KOYA R
MANS DRA
Citation: G. Schwartsmann et al., PHASE-II STUDY OF PENTOSAN POLYSULFATE (PPS) IN PATIENTS WITH AIDS-RELATED KAPOSIS-SARCOMA, Tumori, 82(4), 1996, pp. 360-363
Authors:
MANS DRA
SCALETZKY A
BECKER D
DEOLIVEIRA JR
PINHEIRO CM
BITTAR C
FERREIRA AF
MACHADO VL
RITT JL
JUNG FA
LEYVA A
SCHWARTSMANN G
Citation: Dra. Mans et al., 2 NEW CASES OF HYPERPYRIMIDINURIA ASSOCIATED WITH EXCESSIVE 5-FLUOROURACIL TOXICITY, Annals of oncology, 5(8), 1994, pp. 772-773